Phase 1: Olanzapine
CRC2017ZD03
Phase 3 small_molecule completed
Quick answer
Phase 1: Olanzapine for Schizophrenia is a Phase 3 program (small_molecule) at Shanghai Mental Health Center with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai Mental Health Center
- Indication
- Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed